1-3 of 3
Ryan M Ziemiecki, MS
Close
Sort by
Journal Articles

Patterns of Delivery of Chemoimmunotherapy to Patients with Follicular Lymphoma in the United States: Results of the National Lymphocare Study

Peter Martin, MD, Brian K Link, MD, Michelle Byrtek, PhD, Keith L Dawson, MS, RN, Ryan M Ziemiecki, MS, Jonathan W. Friedberg, MD, James R Cerhan, MD, PhD, Christopher R. Flowers, MD
Journal: Blood
Blood (2012) 120 (21): 3702.
https://doi.org/10.1182/blood.V120.21.3702.3702
Published: 2012
Journal Articles

A Comparison of the Effectiveness of First-Line Chemoimmunotherapy Regimens for Follicular Lymphoma (FL) Used in the United States

Loretta Nastoupil, MD, Rajni Sinha, MD, MRCP, Michelle Byrtek, PhD, Michael Taylor, PharmD, PhD, James R Cerhan, MD, PhD, Jonathan Friedberg, MD, Brian K Link, MD, Ryan M Ziemiecki, MS, Jamie H. Hirata, PharmD, Christopher R Flowers, MD
Journal: Blood
Blood (2011) 118 (21): 97.
https://doi.org/10.1182/blood.V118.21.97.97
Published: 2011
Journal Articles

Examining the Outcomes of Watchful Waiting (WW) Among US Patients with Advanced Stage Follicular Lymphoma (FL)

Rajni Sinha, MD, MRCP, Michelle Byrtek, PhD, Nutan J. DeJoubner, MD, Ajay K. Nooka, MD, MPH, FACP, Michael Taylor, PharmD, PhD, James R Cerhan, MD, PhD, Jonathan Friedberg, MD, Ryan M Ziemiecki, MS, Jamie H. Hirata, PharmD, Brian K Link, MD, Christopher R Flowers, MD
Journal: Blood
Blood (2011) 118 (21): 775.
https://doi.org/10.1182/blood.V118.21.775.775
Published: 2011